PT - JOURNAL ARTICLE AU - Lorenzini, Paolo Alberto AU - Langley, Sarah Raye TI - Multi-omics and Mendelian Randomization network analysis of the association between metabolic and cognitive functions in the UK Biobank Database AID - 10.1101/2024.05.30.24307732 DP - 2024 Jan 01 TA - medRxiv PG - 2024.05.30.24307732 4099 - http://medrxiv.org/content/early/2024/05/31/2024.05.30.24307732.short 4100 - http://medrxiv.org/content/early/2024/05/31/2024.05.30.24307732.full AB - In obese individuals, low levels of leptin, an hormone regulating energy expenditure, have been claimed to be associated with neurodegeneration during ageing. Since leptin signalling system is less potent in the elderly, its protective anti-inflammatory effect in the brain is inhibited and people overweight in middle-age are at higher risk of developing dementia later in life. However, the causal association between obesity and cognitive decline has been inconsistent so far. We incorporated several metabolic and cognitive phenotypes from primary-care health records from European individuals in the UK Biobank to study comprehensively the genetic architecture of metabolic function and cognition. By GWAS analysis, we identified genetic loci in various traits associated with metabolic function and cognitive performance and investigated their genetic association by Mendelian Randomization. Importantly, we identified putatively causality amongst metabolism related traits and that higher adiposity is causally associated with a worse cognitive performance. We conducted a transcriptome-wide association study to identify regulatory effects of the susceptibility variants to pinpoint genes associated with gene expression changes. We integrated the GWAS results with transcriptome and single cell public data to identify tissues and cell types associated with the pathogenesis of metabolic dysfunction and cognition. Overall, this multi-omics approach have proven to be invaluable for demonstrating the causal association between adiposity and cognition and for the discovery of causal variants, genes, tissues and cell types underlying these phenotypes.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe research has been conducted using the UK Biobank Resource (project # 43769). UK Biobank was established by the Wellcome Trust medical charity, Medical Research Council, Department of Health, Scottish Government and Northwest Regional Development Agency. It also had funding from the Welsh Assembly Government, British Heart Foundation and Diabetes UK. The authors are grateful to the UK Biobank participants for making such research possible. This work was supported by the Singapore Ministry of Education under its Singapore Ministry of Education Academic Research Fund Tier 1.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Research Ethics Committee of the UK Biobank gave ethical approval for this work through the approval of application project # 43769.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesThe UKBB phenotypic data and genetic data analysed during the current study are available from UK Biobank. GWAS pre-processing and analysis was performed on the UK Biobank Research Analysis Platform (RAP) following UK Biobank coding guidelines (https://dnanexus.gitbook.io). Bimmer is implemented as an open-source R package available at https://github.com/brielin/bimmer. The deTS tissue enrichment tool is implemented as an open-source R package available at https://github.com/bsml320/deTS.